Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
Cidara Therapeutics (Nasdaq: CDTX), a biotech company specializing in drug-Fc conjugate therapeutics through their proprietary Cloudbreak® platform, has announced their upcoming participation in The Citizens Life Sciences Conference.
The event details include:
- Conference: The Citizens Life Sciences Conference
- Date: Wednesday, May 7, 2025
- Time: 11:00 AM ET
- Format: Presentation
The presentation will be accessible via webcast, and a replay will be available in the Investors section of Cidara's website for at least 30 days. The company will also engage in one-on-one investor meetings during the event.
Cidara Therapeutics (Nasdaq: CDTX), un'azienda biotecnologica specializzata in terapie con coniugati farmaco-Fc attraverso la loro piattaforma proprietaria Cloudbreak®, ha annunciato la sua prossima partecipazione alla Conferenza The Citizens Life Sciences.
I dettagli dell'evento sono i seguenti:
- Conferenza: The Citizens Life Sciences Conference
- Data: Mercoledì 7 maggio 2025
- Orario: 11:00 AM ET
- Formato: Presentazione
La presentazione sarà disponibile tramite webcast, e una replica sarà accessibile nella sezione Investitori del sito web di Cidara per almeno 30 giorni. L'azienda parteciperà inoltre a incontri individuali con investitori durante l'evento.
Cidara Therapeutics (Nasdaq: CDTX), una empresa biotecnológica especializada en terapias con conjugados fármaco-Fc mediante su plataforma propietaria Cloudbreak®, ha anunciado su próxima participación en la Conferencia The Citizens Life Sciences.
Los detalles del evento son los siguientes:
- Conferencia: The Citizens Life Sciences Conference
- Fecha: Miércoles, 7 de mayo de 2025
- Hora: 11:00 AM ET
- Formato: Presentación
La presentación estará disponible vía webcast, y una repetición podrá verse en la sección de Inversores del sitio web de Cidara durante al menos 30 días. La empresa también realizará reuniones individuales con inversores durante el evento.
Cidara Therapeutics (나스닥: CDTX)는 독자적인 Cloudbreak® 플랫폼을 통해 약물-Fc 접합 치료제를 전문으로 하는 생명공학 회사로, 곧 개최될 The Citizens Life Sciences Conference에 참여할 예정임을 발표했습니다.
행사 세부 사항은 다음과 같습니다:
- 컨퍼런스: The Citizens Life Sciences Conference
- 일시: 2025년 5월 7일 수요일
- 시간: 오전 11시 ET
- 형식: 발표
발표는 웹캐스트로 제공되며, Cidara 웹사이트 투자자 섹션에서 최소 30일간 다시보기 서비스를 이용할 수 있습니다. 또한 행사 기간 동안 1:1 투자자 미팅도 진행할 예정입니다.
Cidara Therapeutics (Nasdaq : CDTX), une société biotechnologique spécialisée dans les thérapies par conjugués médicament-Fc via leur plateforme propriétaire Cloudbreak®, a annoncé sa prochaine participation à la conférence The Citizens Life Sciences.
Les détails de l'événement sont les suivants :
- Conférence : The Citizens Life Sciences Conference
- Date : Mercredi 7 mai 2025
- Heure : 11h00 ET
- Format : Présentation
La présentation sera accessible par webcast, et un replay sera disponible dans la section investisseurs du site web de Cidara pendant au moins 30 jours. La société participera également à des rencontres individuelles avec des investisseurs durant l'événement.
Cidara Therapeutics (Nasdaq: CDTX), ein Biotechnologieunternehmen, das sich auf Wirkstoff-Fc-Konjugat-Therapeutika über ihre proprietäre Cloudbreak®-Plattform spezialisiert hat, hat seine bevorstehende Teilnahme an der The Citizens Life Sciences Conference angekündigt.
Die Veranstaltungsdetails sind wie folgt:
- Konferenz: The Citizens Life Sciences Conference
- Datum: Mittwoch, 7. Mai 2025
- Uhrzeit: 11:00 Uhr ET
- Format: Präsentation
Die Präsentation wird per Webcast zugänglich sein, und eine Wiederholung wird für mindestens 30 Tage im Investorenbereich der Cidara-Website verfügbar sein. Das Unternehmen wird während der Veranstaltung auch Einzelgespräche mit Investoren führen.
- Secured presentation slot at a major life sciences investment conference
- Company offers one-on-one investor meetings, indicating active investor relations efforts
- None.
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in The Citizens Life Sciences Conference.
Details are as follows:
Event: The Citizens Life Sciences Conference
Date: Wednesday, May 7, 2025
Time: 11:00 AM ET
Format: Presentation
Webcast: https://wsw.com/webcast/jmp65/cdtx/1686102
A replay of the presentation will be available in the Investors section on the Company’s website at www.cidara.com. The replay of the presentation will be available for at least 30 days.
Cidara will also participate in one-on-one investor meetings during this event.
About Cidara Therapeutics
Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment (Fc). Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation. In June 2023, CD388 was granted Fast Track Designation by the U.S. Food and Drug Administration (FDA), and the Company announced completion of Phase 2b enrollment in December 2024. Additional DFCs have been developed for oncology and in July 2024 Cidara received IND clearance for CBO421 which is intended to target CD73 in solid tumors. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.
INVESTOR CONTACT:
Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com
MEDIA CONTACT:
Michael Fitzhugh
LifeSci Communications
mfitzhugh@lifescicomms.com
FAQ
When is Cidara Therapeutics (CDTX) presenting at The Citizens Life Sciences Conference 2025?
How can I watch Cidara Therapeutics' (CDTX) Citizens Conference presentation?
What is Cidara Therapeutics' (CDTX) main technology platform?
Will Cidara Therapeutics (CDTX) offer one-on-one meetings at the Citizens Life Sciences Conference?
Where can investors find the replay of Cidara's (CDTX) Citizens Conference presentation?
